News

Event
Partner
Milestone
Milestone
2020-11-17

ACT Genomics Have Been Awarded With ISO/IEC 27001 Certification

The ISO/IEC 27001 certification helps to increase clients’ confidence in our information security management, enabling us to promote innovative cancer genomic profiling services with our international partners.

Place:

Taiwan

Milestone
2020-11-17

ACT Genomics Is The Member Of The Global Alliance For Genomics And Health (GA4GH)

ACT Genomics is now an organizational member of the Global Alliance for Genomics and Health (GA4GH) and we will continue to promote cancer precision medicine.

Place:

Taiwan

Partner
2020-11-10

Teddy Lab, A Central Lab Partner Of ACT Genomics, And AstraZeneca China Signed Strategic MOU To Develop Cancer Precision Medicine Solution In China

Teddy Lab and AstraZeneca China signed strategic MOU for the CDx development of HRD, the standardization of sequencing and commercialization to provide cancer patients precision diagnosis and treatment as one-stop service.

Place:

China

Milestone
2020-10-22

11/07 & 08 Upcoming Annual 7th Hong Kong International Oncology Symposium

ACT Genomics co-organizes the 7th Hong Kong International Oncology Symposium (HKIOS) to invite experts to share their first-hand experience with this groundbreaking advances in cancer management to speed up the progress of clinical practice.

Place:

Hong Kong

Milestone
2020-09-29

ACT Genomics and Nan Shan Life Insurance Cooperates To Promote High-Quality Cancer Precision Medicine Services

To provide better care for cancer patients in precision medicine, strategic cooperations among biotech and insurance company are on the rise. We are happy to announce that ACT Genomics cooperates with Nan Shan Life Insurance for precision medicine project

Place:

Taipei

Milestone
2020-09-28

ACTRisk™ Genetic Test For Hereditary Cancers - Start You & Your Family's Hereditary Medical Plan Better And Earlier

Approximately 5–10% of cancers are caused by inherited genetic mutations, and through high-quality hereditary genetic test ACTRisk™ , you and your family can start your hereditary medical plan better and earlier.

Place:

Taipei

Milestone
2020-09-07

ACT Genomics Completed the First Closing of latest Round of Equity Financing

ACT Genomics is pleased to announce the completion of the first closing of the latest round of equity financing from a group of strategic investors including Aflac Ventures LLC and Kyoto University Innovation Capital.

Place:

Asia

Milestone
2020-07-28

Information Security Policy

Strengthen personnel knowledge and ability, avoid data leakage and ensure that services are available

Place:

Taiwan

Partner
2020-06-20

A Joint Clinical Research Collaboration among ACT Genomics, Kaohsiung Medical University (KMU), and National Health Research Institutes (NHRI) Seeks to Investigate the Genomic Landscape of Melanoma in Taiwan

ACT Genomics, Kaohsiung Medical University (KMU), and National Health Research Institutes (NHRI) launched a joint clinical research collaboration aimed to establish comprehensive genomic profiles of Melanoma within the Taiwanese population

Place:

Taiwan

Event
2020-06-05

ACT Genomics Is At A Fresh Turning Point Under COVID-19 In 2020 US BIO Digital

ACT Genomics is chosen by Taipei City Government as representative to join US BIO Digital, the world’s largest biotechnology exhibition, with OBI Pharma, belxbiopharma, NatureWise Biotech & Medicals, Far East Bio-tec and AcroMass Technology.

Place:

Taipei